Q2 2024 Holdings
Filed 2024-08-14 | 433 holdings | $6.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $1.5B | 19,991,024 | 25.2% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $258.7M | $151,408,000 | 4.3% |
| Viatris Inc(VTRS) | COM | 92556V106 | $227.4M | 21,395,496 | 3.8% |
| Centene Corp del(CNC) | COM | 15135B101 | $175.7M | 2,650,122 | 2.9% |
| Integra Lifesciences Hldgs C | NOTE 0.500% 8/1 | 457985AM1 | $164.5M | $174,364,000 | 2.7% |
| Brookdale SR Living Inc | NOTE 2.000%10/1 | 112463AC8 | $163.3M | $161,905,000 | 2.7% |
| Merus N V | COM | N5749R100 | $162.7M | 2,749,401 | 2.7% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $153.9M | 21,231,974 | 2.6% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $141.4M | 9,127,305 | 2.4% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $132.6M | 13,257,940 | 2.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $119.9M | 3,090,073 | 2.0% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $115.5M | $132,598,000 | 1.9% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $112.0M | 4,707,287 | 1.9% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $111.4M | 5,411,571 | 1.9% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $110.1M | 6,959,787 | 1.8% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $106.6M | 15,612,264 | 1.8% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $106.5M | 4,952,004 | 1.8% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $102.3M | 1,491,000 | 1.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $95.1M | 691,004 | 1.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $94.3M | 11,077,927 | 1.6% |
| Mirum Pharmaceuticals Inc | NOTE 4.000% 5/0 | 604749AB7 | $93.8M | $70,000,000 | 1.6% |
| Owens & Minor Inc New(ACH) | COM | 690732102 | $86.0M | 6,371,440 | 1.4% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $85.2M | 10,901,485 | 1.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $73.6M | 2,097,113 | 1.2% |
| Hillevax Inc | COM | 43157M102 | $57.9M | 4,004,231 | 1.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $57.6M | 975,000 | 1.0% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $57.2M | 3,280,237 | 1.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $52.8M | 1,577,647 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $51.8M | 2,874,586 | 0.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $50.3M | 8,135,804 | 0.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $47.7M | 594,000 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $46.1M | 1,023,265 | 0.8% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $44.6M | 4,997,746 | 0.7% |
| Conmed Corp(CNMD) | COM | 207410101 | $43.8M | 631,264 | 0.7% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $42.8M | 1,467,632 | 0.7% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $41.4M | 151,714 | 0.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $40.3M | 2,923,137 | 0.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $35.0M | 1,411,000 | 0.6% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $34.1M | 2,726,135 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $33.2M | 844,407 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $31.6M | 3,744,263 | 0.5% |
| Lantheus Hldgs Inc | NOTE 2.625%12/1 | 516544AB9 | $31.5M | $25,255,000 | 0.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $29.1M | 119,800 | 0.5% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $28.1M | 2,817,763 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $26.3M | 1,397,279 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $24.2M | 6,710,429 | 0.4% |
| Insulet Corp(PODD) | COM | 45784P101 | $22.7M | 112,433 | 0.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $22.5M | 3,799,143 | 0.4% |
| Docgo Inc(DCGO) | COM | 256086109 | $22.2M | 7,195,956 | 0.4% |
| Inmode LTD(INMD) | SHS | M5425M103 | $21.3M | 1,166,704 | 0.4% |